BEAM vs CLOV
Beam Therapeutics Inc (BEAM) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BEAM currently screens at market cap $2.01B. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BEAM and CLOV stock pages for the full models.
Not investment advice.